Blog

In vivo research plays a pivotal role in the development of innovative therapeutics, particularly biologics. As researchers and drug developers continue to explore new targets and refine existing therapies, high-quality research tools like Benchmark Positive Antibodies are essential. These anti-huma

Antibodies have applications across research, diagnostics, and therapeutics. Their high specificity, selectivity, and ability to recognize and bind to specific antigens makes them essential for applications like selection, identification, purification, and disease treatment. Antibodies are generally categorized into two main groups: polyclonal antibodies (pAbs) and monoclonal antibodies (mAbs).

The 15th Annual World Bispecifics Summit 2024 was held in Boston, MA on September 3-5, 2024. The event brought together experts in the field of bi, tri and multi-specifics, in addition to bispecific ADCs and BiTEs.

The neonatal Fc receptor, or FcRn, plays an important role in both maternal IgG transport and protection of IgG from degradation.

Antibodies are versatile molecules that perform a range of effector functions, many of which engage different arms of the immune system. Their modes of action extend beyond simple antigen binding, enabling the activation of various immune mechanisms that lead to pathogen neutralization and clearance. These functions include blocking molecular interactions, activating the complement system, and linking the humoral immune response to cellular immune responses via Fc receptor engagement.

In today’s competitive biotech landscape, intellectual property (IP) protection has become an essential pillar in fostering innovation and collaboration across drug discovery and development. By offering clear IP terms and no royalty fees,pharmaceutical companies and research institutes

In addition to isotypes and subtypes, antibodies exhibit genetic variation known as allotypes, which are polymorphic epitopes on immunoglobulins. These allotypic differences arise from allelic variations in immunoglobulin genes, causing certain antibody subtypes to differ between individuals or ethnic groups. The presence of these polymorphic forms can influence immune responses, particularly when an individual is exposed to a non-self allotype, potentially triggering an anti-allotype immune reaction.

In mammals, antibodies are classified into five major isotypes: IgA, IgD, IgE, IgG, and IgM. Each isotype is defined by the heavy chain it contains: alpha (IgA), delta (IgD), epsilon (IgE), gamma (IgG), or mu (IgM). These structural differences in the heavy chains determine the antibody's function, tissue localization, and role in the immune response. Furthermore, antibody light chains fall into two classes—kappa and lambda—with kappa being more common, though both exhibit similar functions despite differences in sequence.

Antibody generation can be approached through two main methods: in vivo (within a living organism) and in vitro (in a laboratory setting). Below is a comparison of their advantages, drawbacks, and technical differences.AdvantagesCategoryIn VivoIn VitroAntigen Format CompatibilityBroad, including nat

Antibodies, a key element of the immune system, play dual roles through two distinct structural regions: the antigen-binding fragment (Fab) and the crystallizable fragment (Fc). These regions not only bind antigens but also trigger immune responses that facilitate antigen clearance. The Fab region,

Monoclonal antibodies (mAbs) are essential tools in therapeutic development, diagnostics, and research. Among the various methods for generating human monoclonal antibodies, two popular technologies are: phage display and transgenic mice. While both methods have their merits, transgenic mice are particularly valuable for creating fully human antibodies through the natural immune processes of the animal.

The history of antibodies traces back several centuries and forms the cornerstone of modern immunology. From the early discovery of immunity through exposure to disease, to the detailed molecular understanding of antibodies today, the development of antibody research has been transformative for both basic science and applied biotechnology, particularly in therapeutic antibody production.